Will the Headache Field Embrace Rofecoxib (Vioxx)? : compare

Experts discuss the history of rofecoxib, including its market withdrawal and subsequent resurrection. The once-bestselling painkiller known as Vioxx is now proceeding to a phase 3 trial for migraine.

Related Keywords

California , United States , Joseph Ross , Alanm Rapoport , Los Angeles , Brad Sippy , Eli Lilly , Yale University , University Of California , Amgen , Drug Administration , John Arnold Foundation , Medscape Professional Network , International Headache Society , Tremeau Pharmaceuticals , Locala Health , Device Innovation Consortium , Lundbeck , Different Mechanism , Neurology Reviews , International Headache , Unique Risks , Prescribed Doses , New Haven , Collegium Pharmaceutical , Medical Device Innovation Consortium , Medscape Professional ,